PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a finished-dose generic company from India

Selling into Europe as a finished-dose generic company from India

Your generics reach European buyers sooner when your dossiers pass validation first time.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • India, Finished-dose generic companywho it is written for

Why this training matters

Your Regulatory Affairs Manager opens the deficiency letter and finds the stability data in Module 3 does not support the shelf life you claimed. The team rewrites the dossier while your finished-dose generic waits at your plant. A competitor wins the tender you planned for.

What changes after this course

Your team files Modules 1, 2 and 3 that answer the assessor before the question is asked, and meets inspectors with exact EudraLex Volume 4 references. You hold a certificate per learner and a training record per person, ready for your next audit.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team picks the submission route in one meeting. They test each product against the Decentralised, Mutual Recognition and Centralised Procedures, then write Common Technical Document Modules 1 and 2 so the agency validates the file instead of sending it back. Nobody waits for an outside consultant to say which form belongs where.

At the next Good Manufacturing Practice inspection, your quality head answers with chapter and clause. They audit your Indian sites against EudraLex Volume 4 and Annex 1 before the inspector does, and they close gaps in the contamination control strategy. Module 3 stability data is laid out to match European climatic zone expectations, so assessors have fewer reasons to write queries.

Your pharmacovigilance officer builds the Pharmacovigilance System Master File to the content rules of Good Pharmacovigilance Practice Module II. The Qualified Person for Pharmacovigilance knows what goes to EudraVigilance and when. Your supply chain director checks Good Distribution Practice standing with every wholesaler and sets up packaging for Falsified Medicines Directive serialisation.

Commercial staff stop sending tender bids that ignore reference pricing. Before a bid goes out, they see how a low price in one member state reaches others. Marketing checks every claim against the Summary of Product Characteristics and national advertising rules, and regulatory staff pick Type IA, Type IB or Type II for each change.

Who needs this training

  • Regulatory Affairs Manager

    You face an empty Module 1 and need to know which administrative forms each national authority expects in a Decentralised Procedure file, before the submission date is fixed.

  • Head of Quality Assurance

    You hold the inspection agenda in one hand and EudraLex Volume 4 in the other, and need your site master file to answer every question the inspector plans to ask.

  • Supply Chain Director

    A shipment of finished-dose generics sits on hold because a distribution partner cannot show Good Distribution Practice compliance for its European warehouse.

  • Pharmacovigilance Officer

    A European partner asks for proof that your adverse event reporting meets Good Pharmacovigilance Practice, and you must update the Pharmacovigilance System Master File within days.

  • Business Development Lead for Europe

    In the pricing meeting you must show how a low tender bid in one member state could pull down the reference price in other countries.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Finished-dose generic company

Countries: India

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Select the correct European authorisation procedure for a finished-dose generic by testing it against the eligibility rules of each route.
  2. Compile Common Technical Document Module 1 and the Module 2 overviews so the file passes validation.
  3. Audit a manufacturing site against EudraLex Volume 4 and Annex 1 and list the gaps before an inspector does.
  4. Draft a Pharmacovigilance System Master File that follows Good Pharmacovigilance Practice Module II.
  5. Check that a logistics partner holds valid Good Distribution Practice standing before product ships to a European wholesaler.
  6. Estimate how a tender price in one member state can affect reference prices in other states.
  7. Choose between a Type IA, Type IB and Type II variation for a given manufacturing change.

What the company gets

  • Your dossiers reach the reviewing authority in a state that passes validation, so authorisation is not held up by avoidable administrative returns.
  • Your sites meet European Union inspectors with an internal audit already done against EudraLex Volume 4, and with straight answers on contamination control.
  • Your commercial team sets tender prices knowing how they travel across member states, which protects margins in markets you have not yet entered.
  • Your marketing materials are checked against national advertising rules before they reach a physician, which keeps your brand away from disputes with health authorities.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Map which European rules apply to your generic, EU-wide or national

    • Why a dossier that works in one member state stalls in the next, and how to see it before filing.
    • How to find the national agency guideline that applies when European Medicines Agency guidance runs out.
    • The member-state differences that decide which market you enter first.
  2. 2Choose the fastest route to market authorisation for each product

    • When the Decentralised Procedure fits your product and when Mutual Recognition does.
    • How to check your product against Centralised Procedure eligibility before you plan around it.
    • What the procedural timetables mean for your launch date, so you choose the route with the shorter wait.
  3. 3Write Common Technical Document Modules 1 and 2 that pass validation

    • What goes into Module 1 so the agency validates your file instead of returning it on day one.
    • How to place bioequivalence data in the Module 2 clinical overview so the assessor finds it at once.
    • The expert qualifications and signed declarations behind the Module 2 overviews, and the Module 1 section where they are filed.
  4. 4Build Common Technical Document Module 3 so quality queries never start

    • Why section 3.2.P.2 must justify every excipient you chose, and how to write that justification.
    • How to present stability data so it answers European climatic zone expectations without a query.
    • The manufacturing process detail assessors look for in Module 3, so fewer questions come back.
  5. 5Pass your European Union Good Manufacturing Practice inspection

    • How to prepare your site master file so the inspector's first hour goes your way.
    • What to do when an inspector questions your contamination control strategy under Annex 1.
    • The critical observations that recur in EudraLex Volume 4 inspections and the checks that prevent them.
  6. 6Build a Pharmacovigilance System Master File that meets European rules

    • Why your Qualified Person for Pharmacovigilance must be based in the European Economic Area.
    • How to structure the Pharmacovigilance System Master File so a routine inspection finds every answer.
    • Who reports serious adverse reactions to EudraVigilance, and the deadlines your team must meet.
  7. 7Align your supply chain with European Good Distribution Practice

    • How to check a logistics partner's Good Distribution Practice standing before the first shipment moves.
    • What happens to your batches when the Falsified Medicines Directive serialisation check fails.
    • The responsibilities that stay with you when product passes to a European wholesaler.
  8. 8Price your generic for European tenders and reimbursement

    • How national pricing bodies value a generic, so your offer matches how they calculate.
    • Why a price in one country pulls on your price in others, and how to plan around it.
    • The data a hospital tender asks for in decentralised health systems, ready before the deadline.
  9. 9Clear promotional materials through European advertising rules

    • Why advertising prescription medicines to the public is banned in the European Union.
    • How to draft promotional claims that stay inside the approved Summary of Product Characteristics.
    • The national rules your materials must meet before they reach a European physician.
  10. 10File post-marketing variations without interrupting your supply

    • When a manufacturing change is a Type IA variation and when it becomes Type II.
    • How to time your Marketing Authorisation renewal so approval never lapses.
    • The safety reporting duties that stay with you long after launch.
  11. 11Screen European local partners before they delay your launch

    • Why thin due diligence on a local partner stalls your launch, and the checks that prevent it.
    • How to read a partner's licences and track record before you sign anything.
    • The business-culture habits that stall contract talks with European distributors.
  12. 12Gather regulatory intelligence from European trade bodies early

    • How to use European trade associations to hear about rule changes before they take effect.
    • Which professional bodies to join for a route to regulatory discussions.
    • What a local network needs so your European operation keeps pace with change.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for India, Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team